Eric Devor

Research Assistant Professor

The University of Iowa Roy J and Lucille A Carver College of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Eric Devor is a Research Assistant Professor at the University of Iowa Roy J and Lucille A Carver College of Medicine, USA. His research focuses on the molecular and genomic aspects of gynecological cancers, including ovarian and endometrial cancer. Recent publications highlight his work on identifying cell populations in ovarian cancer, enhancing progestin therapy, and integrating genomic data to improve cancer treatment outcomes.

Articles (12)

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Michael Goodheart

The University of Iowa University College

UNITED STATES

View details

Jesus Gonzalez Bosquet

Iowa State University

UNITED STATES

View details

Thorsten Maretzky

Assistant Professor

Iowa State University

UNITED STATES

View details

Kristina Thiel

Assistant Professor

Iowa State University

UNITED STATES

View details

Cara Mathews

Assistant Professor

UNITED STATES

View details

Brian Smith

Professor

Iowa State University

UNITED STATES

View details

David Bender

The University of Iowa University College

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eric Devor

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer

scRNA-seq Can Identify Different Cell Populations in Ovarian Cancer Bulk RNA-seq Experiments

Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation

Integration of Genomic and Clinical Retrospective Data to Predict Endometrioid Endometrial Cancer Recurrence

Placenta-specific protein 1 (PLAC1) expression is significantly down-regulated in preeclampsia via a hypoxia-mediated mechanism

Using Genomic Variation to Distinguish Ovarian High-Grade Serous Carcinoma from Benign Fallopian Tubes

TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy.

The Synthetic Curcumin Analog HO-3867 Rescues Suppression of PLAC1 Expression in Ovarian Cancer Cells

Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer

Collaborators (7)

Michael Goodheart

Jesus Gonzalez Bosquet

Thorsten Maretzky

Kristina Thiel

Cara Mathews

Brian Smith

David Bender

Make your next move.